Citizens Financial Group’s Charles River Laboratories CRL Stock Holding History

Citizens Financial Group’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-73	Closed	-$13K	–	396
2020 Q2	$13K	Hold	73	–	–	﹤0.01%	710
2020 Q1	$9K	Hold	73	–	–	﹤0.01%	765
2019 Q4	$11K	Sell	73 -28	-28%	-$3.88K	﹤0.01%	729
2019 Q3	$13K	Hold	101	–	–	﹤0.01%	516
2019 Q2	$14K	Buy	101 +54	+115%	+$7.32K	﹤0.01%	494
2019 Q1	$7K	Sell	47 -3	-6%	-$394	﹤0.01%	545
2018 Q4	$6K	Hold	50	–	–	﹤0.01%	423
2018 Q3	$7K	Hold	50	–	–	﹤0.01%	441
2018 Q2	$6K	Hold	50	–	–	﹤0.01%	412
2018 Q1	$5K	Hold	50	–	–	﹤0.01%	417
2017 Q4	$5K	Hold	50	–	–	﹤0.01%	453
2017 Q3	$5K	Sell	50 -14	-22%	-$1.44K	﹤0.01%	446
2017 Q2	$6K	Hold	64	–	–	﹤0.01%	443
2017 Q1	$6K	Hold	64	–	–	﹤0.01%	480
2016 Q4	$5K	Hold	64	–	–	﹤0.01%	528
2016 Q3	$5K	Hold	64	–	–	﹤0.01%	529
2016 Q2	$5K	Hold	64	–	–	﹤0.01%	543
2016 Q1	$5K	Buy	64 +8	+14%	+$592	﹤0.01%	509
2015 Q4	$5K	Buy	+56	New	+$4.04K	﹤0.01%	544

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Citizens Financial Group's CRL Position: Q3 2020 in Review

Citizens Financial Group sold out of Charles River Laboratories (CRL) in Q3 2020, closing a stake of 73 shares — an estimated $13K sold.

Citizens Financial Group first reported a position in CRL in Q4 2015 and held it in 19 quarters. The position peaked at $14K in Q2 2019. 491 funds tracked by Wall St. Rank hold CRL as of Q3 2020.

Citizens Financial Group reported no remaining Charles River Laboratories position as of Q3 2020 after selling out during the quarter.
Citizens Financial Group sold 73 Charles River Laboratories shares in Q3 2020, an estimated $13K.
Citizens Financial Group first reported a position in Charles River Laboratories in Q4 2015 and held it in 19 quarters.
Citizens Financial Group's Charles River Laboratories position peaked at $14K in Q2 2019.
491 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.